Short-term 30-day adverse events following awake versus asleep deep brain stimulation for movement disorders: a nationwide registry-based study

Introduction: Deep Brain Stimulation (DBS) is FDA-approved for the management of medically refractory movement disorders and epilepsy. We aim to assess potential differences in adverse eventsamong patients undergoing asleep versus awake DBS, to facilitate a patient centric decision-making process fo...

Full description

Saved in:
Bibliographic Details
Main Authors: Victor Gabriel El-Hajj, Ryan Nguyen, Abdul Karim Ghaith, Victor E. Staartjes, Christian Möhrlen, Adrian Elmi-Terander, Rushna Ali
Format: Article
Language:English
Published: Elsevier 2025-01-01
Series:Brain and Spine
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S2772529425002127
Tags: Add Tag
No Tags, Be the first to tag this record!